Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
Trial Parameters
Brief Summary
The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.
Eligibility Criteria
Inclusion Criteria: Project 1: HealthKit * Individuals who meet at least one of the following criteria: * Diagnosis of new onset early-stage (I-III), low-grade (I-II), or locally advanced solid tumor * Historical diagnosis of primary invasive solid tumor * Diagnosis of metastatic (stage IV) or high-grade (III-IV) disease * Enrolled onto an investigational trial in the EDD Service * Seen in the MSK UCC from 2021 and onwards * Completion of Survivorship Patient Self-Assessment * Adult without a history of cancer \<50 years of age * Adult without a history of cancer ≥ 50 years of age * ≥18 years old * Own an Apple iPhone with valid iOS operating software * Have a registered MSK MyChart account and be willing to download the MSK Remote Monitoring (RM) application onto their personal iPhone * Self-reported "very well" comprehension of written and verbal English language * Willing and able to provide informed consent and HIPAA authorization for the release of personal health information Proj